Biotech Vertex Pharmaceuticals stock tumbled on news of disappointing drug data. CEO Reshma Kewalramani paid nearly $4 ...

Detailed price information for Ptc Therapeutics (PTCT-Q) from The Globe and Mail including charting and trades.

And one of the best ways to cash in on that is to invest in stocks that can exceed the market's performance. Two that look ...

RTX Corporation has seen a significant reshuffle in its shareholder base. Barnett & Company Inc. slashed its stake in RTX by 29.1%, now holding shares worth about $2.2 million. This positions RTX as ...

Vertex Pharmaceuticals shows promising signs despite a recent price drop. Strong fundamentals underscore its market position, ...